Have experienced a frustrating weight loss plateau
Add what you need to your cart no account required
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
Recalls & Warnings June 21, 2005 FTC Settles Claims with Marketers of FiberThin and Propolene On June 20, 2005, the Federal Trade Commission (FTC) announced that the marketers of the dietary supplements FiberThin and Propolene have settled FTC charges that their misleading weight-loss claims violated federal laws
Why not just buy vitamins at the drug store
Evidence Gene-expression and wound-healing research support the matrix-remodeling mechanism